WHO ICTRP trial

Evaluation of therapeutic effect of intracordal bFGF administration on vocal…

JPRN-jRCTs031220682 · Japan Primary Registries Network (JPRN) · Recruiting

Key facts

Trial ID JPRN-jRCTs031220682
Public title Evaluation of therapeutic effect of intracordal bFGF administration on vocal fold atrophy (including presbylarynx), sulcus vocalis
Scientific title Evaluation of therapeutic effect of intracordal bFGF administration on vocal fold atrophy (including presbylarynx), sulcus vocalis
Primary sponsor Ueha Rumi
Registry Japan Primary Registries Network (JPRN)
Recruitment status Recruiting
Study type Interventional
Phase 2
Conditions ocal fold atrophy (including presbylarynx), sulcus vocalis ocal fold atrophy, sulcus vocalis;ocal fold atrophy, sulcus vocalis
Interventions Inject trafermin into the vocal cords for vocal fold atrophy (including presbylarynx) or sulcus vocalis;bFGF
Registration date Mar 3, 2023
Target size 33
Registry page jrct.niph.go.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations